Andrew Patient

Andrew Patient is a declared insider of Intellipharmaceutics International Inc., with filings sourced from SEDI. The record holds 5 filings, for trades running from 6 September 2017 to 14 May 2018.

Purchases make up the whole of the open-market record (4 purchases, €24k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2018 alone, the filings show 4 purchases and no sales.

In size, the median ticket on the buying side is €6,522. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

The record was last updated on 14 May 2018 with an open-market purchase (€7,664) in Intellipharmaceutics International Inc. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.